CRP and hyperlipidemia: In healthy persons without hyperlipidemia but with elevated high-sensitivity CRP levels, rosuvastatin, which lowered high-sensitivity CRP as well as cholesterol levels, reduced the incidence of stroke and myocardial infarction by 50% relative to placebo [104].